Alto Neuroscience, Inc. (ANRO) ROI
- 2026-06-30: ROI -35.78%.
- 2026-03-31: ROI -28.65%.
- 2025-12-31: ROI -37.66%.
- 2024-12-31: ROI -37.99%.
Complete source-backed roi history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -35.78% |
| 2026-03-31 | -28.65% |
| 2025-12-31 | -37.66% |
| 2024-12-31 | -37.99% |
| 2024-09-30 | -32.79% |
| 2024-06-30 | -26.24% |
| 2024-03-31 | -20.90% |
| 2023-12-31 | 58.74% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | -37.66% |
| 2024-12-31 | -37.99% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |